Meeting Coverage

GuCS Future Focus

Further studies warranted in this sub-disease state, says Daniel Petrylak, MD

The future is "bright" with enfortumab vedotin and pembrolizumab, says Daniel Petrylak, MD

March 15, 2023

Shilpa Gupta, MD, offered an interesting proposition at the Genitourinary Cancers Symposium

March 8, 2023

Gary Steinberg, MD, discusses key abstracts from the Genitourinary Cancers Symposium

March 1, 2023